Celltrion
068270.KS
#832
Rank
โ‚น2.887 T
Marketcap
โ‚น12,589
Share price
2.31%
Change (1 day)
16.94%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): โ‚น227.53

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น242.58. In 2025 the company made an earnings per share (EPS) of โ‚น296.79 an increase over its 2024 EPS that were of โ‚น112.56.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น227.53-23.34%
2025โ‚น296.79163.66%
2024โ‚น112.56-53.73%
2023โ‚น243.29-2.08%
2022โ‚น248.45-11.72%
2021โ‚น281.442.03%
2020โ‚น275.8382.8%
2019โ‚น150.8918.31%
2018โ‚น127.54-36.33%
2017โ‚น200.32161.25%
2016โ‚น76.682.86%
2015โ‚น74.5517.84%
2014โ‚น63.265.87%
2013โ‚น59.75-70.85%
2012โ‚น204.98134.09%
2011โ‚น87.5643.59%
2010โ‚น60.9874.49%
2009โ‚น34.95317.8%
2008โ‚น8.36-71.7%
2007โ‚น29.56